Desensitization in normal and neoplastic human thyroid cell lines

World Journal of Surgery

Volumn 22, Issue 6, 1998, Pages 552-557

  Al Sobhi, Saif S ^a   Soh, Euy Y ^b   Wong, Mariwil G ^c   Siperstein, Allan E ^c   Duh, Quan Yang ^a,c   Clark, Orlo H ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Ajou University School of Medicine   (South Korea)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THYROTROPIN;

ADULT; AGED; CANCER CELL CULTURE; CANCER GROWTH; CLINICAL ARTICLE; CONFERENCE PAPER; DESENSITIZATION; DOSE RESPONSE; HUMAN; THYROID PAPILLARY CARCINOMA; THYROTROPIN BLOOD LEVEL;

AGED; CELL LINE; CYCLIC AMP; HUMANS; MIDDLE AGED; THYROID GLAND; THYROID NEOPLASMS; THYROTROPIN; TUMOR CELLS, CULTURED;

EID: 0031926081     PISSN: 03642313     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002689900433     Document Type: Conference Paper

References (30)

1. Clark, O.H.: TSH suppression in the management of thyroid nodules and thyroid cancer. World J. Surg. 5:39, 1981
2. Greer, M.A., Astwood, E.B.: Treatment of simple goiter with thyroid. J. Clin. Endocrinol. Metab. 13:1312, 1953
3. Berghout, A., Wiersinga, W.M., Drexhage, H.A., Smits, N.J., Touber, J.L.: Comparison ot placebo with levothyroxine alone or with carbimazole for the treatment of sporadic non-toxic goiter. Lancet 336:193, 1990
4. Morita, T., Tamai, H., Ohshima, A., Kamaki, G., Matsubayashi, S., Kuma, K., Nakagama, T.: Changes in serum thyroid hormone, thyrotropin and thyroglobulin concentrations during thyroxine therapy in patients with solitary thyroid nodules. J. Clin. Endocrinol. Metab. 69:227, 1989
5. Clark, O.H., Duh, Q.Y.: Thyroid growth factors and oncogenes. In Oncogenes and Tumor Suppressor Genes in Human Cancer, C.C. Benz, T. Liu, editors. Boston, Kluwer, 1993, pp. 87-104
6. Zbar, A.P., O'Higgins, N.J.: Use and abuse of thyroid stimulating hormone suppressive therapy in patients with nodular goiter and benign and malignant thyroid neoplasms. In Textbook of Endocrine Surgery, O.H. Clark, Q.Y. Duh, editors. Philadelphia, W.B. Saunders, 1997, pp. 54-68
7. Gharib, H., James, E.M., Charboneau, J.W., Naessens, J.M., Offord, K.P., Gorman, C.A.: Suppressive therapy with levothyroxine for solitary thyroid nodules. N. Engl. J. Med. 317:10, 1987
8. Burmeister, L.A., Goumaz, M.O., Mariash, C.N., Oppenheimer, J.H.: Levothyroxine dose requirements for thyrotropin suppression in the treatment of differentiated thyroid carcinoma. J. Clin. Endocrinol. Metab. 75:344, 1992
9. Mazzaferri, E.L., Jhiang, S.M.: Long term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am. J. Med. 97:418, 1994
10. Pujol, P., Daures, J.A., Nsakala, N., Baldet, L., Bringer, J., Jaffiol, C.: Degree of thyrotropin suppression as a prognostic determinant in differentiated thyroid cancer. J. Clin. Endocrinol. Metab. 81:4318, 1996
11. Clark, O.H.: Role of TSH suppression as adjuvant therapy for patients with differentiated thyroid cancer of follicular cell origin. In Thyroid Cancer, S. Noguchi, O.H. Clark, editors. Austin, TX, R. Landes, (in press)
12. Clark, O.H., Hoelting, T.: Management of patients with differentiated thyroid cancer who have positive serum thyroglobulin levels and negative radioiodine scans. Thyroid 4:501, 1994
13. 131I whole body scans in the diagnosis of metastases from differentiated thyroid carcinoma (after thyroidectomy). Clin. Endocrinol. (Oxf.) 13:107, 1980
14. Pineda, J.D., Lee, T., Ain, K., Reynolds, J.C., Robbins, J.: Iodine-131 therapy for thyroid cancer patients with elevated thyroglobulin and negative diagnostic scans. J. Clin. Endocrinol. Metab. 80:1488, 1995
15. Tezelman, S., Shaver, J.K., Grossman, R.F., Liang, W., Siperstein, A.E., Duh, Q.Y., Clark, O.H.: Desensitization of adenylale cyclase in Chinese hamster ovary cells transfected with human thyroid stimulating hormone receptor. Endocrinology 154:1561, 1994
16. Rapoport, G., Adams, R.J.: Induction of refractoriness to thyrotropin stimulation in cultured thyroid cells. J. Biol. Chem. 251:6653, 1976
17. Breton, M.F., Haye, B., Omri, B., Jacquemin, C., Pavlovic-Hournac, M.: Decrease in cAMP dependent protein kinase activity in suspension cultures of porcine thyroid cells exposed to TSH or forskolin. Mol. Cell. Endocrinol. 55:243, 1988
18. Rogers, P.P., Breton, M.F., Dumont, J.E., Pavlovic-Hournac, M.: Epidermal growth factor and phorbol ester actions on the TSH induced down regulation of the isoenzyme I (PKAI) of cyclic AMP-dependent protein kinase in dogs' thyroid and primary cultures. Cell. Signal. 3:145, 1991
19. Clark, O.H., Gerend, P.L., Gote, T.C., Nissonson, R.A.: Thyrotropin binding and adenylate cyclase stimulation in thyroid neoplasms. Surgery 90:252, 1981
20. Van Sande, J., Raspe, E., Perret, J., Lejeune, C., Maenhaut, C., Vassart, G., Dumont, J.E.: Thyrotropin activates both the cyclic AMP and the PIP2 cascades in CHO cells expressing the human cDNA of TSH receptor. Mol. Cell. Endocrinol. 74:R1, 1990
21. Hoelting, T., Tezelman, S., Siperstein, A.E., Duh, Q.Y., Clark, O.H.: Thyrotropin stimulates invasion and growth of follicular thyroid cancer cells via PKC-rather than PKA-activation. Biochem. Biophys. Res. Commun. 195:1230, 1993
22. Siperstein, A., Zeng, Q.H., Gum, E., Levin, K., Clark, O.H.: Adenylate cyclase activity as a predictor of thyroid tumor aggressiveness. World J. Surg. 12:528, 1988
23. Siperstein, A.E., Miller, R.A., Landis, C., Bourne, H., Clark, O.H.: Increased stimulatory G protein in neoplastic human thyroid tissues. Surgery 110:949, 1991
24. Lyons, J., Landis, C.A., Harsh, G., Dallar, L., Grunewald, K., Feichtinger, H., Duh, Q.Y., Clark, O.H., Kawasaki, E., Bourne, H.R., McCormick, F.: Two G protein oncogenes in human endocrine tumors. Science 249:655, 1990
25. Goretzki, P.E., Lyons, J., Stacey-Phipps, S., Rosenau, W., Demeure, M.J., Clark, O.H., McCormick, F., Rocher, H.D., Bourne, H.R.: Mutational activation of RAS and GSP oncogenes in differentiated thyroid cancer and their biological implications. World J. Surg. 116:576, 1992
26. Russo, D., Tumino, S., Arturi, F., Vigneri, P., Grasso, G., Pontecoro, A., Feletti, S., Belfiore, A.: Detection of an activating mutation of the thyrotropin receptor in a case of an autonomously hyperfunctioning thyroid insular carcinoma. J. Clin. Endocrinol. Metab. 52:735, 1997
27. Shaver, J.K., Tezelman, S., Siperstein, A.E., Duh, Q.Y., Clark, O.H.: TSH activates phospholipase C in normal and neoplastic thyroid. Surgery 114:1064, 1993
28. 3H) thymidine incorporation in rat FRTL-5 cells. J. Endocrinol. 138:319, 1973
29. Gallo, A., Benusiglio, E., Bonapace, I.M., Feliciello, A., Cassano, S., Garbi, C., Musti, A.M., Gottesman, M.E., Avvedimento, E.V.: V-ras and protein kinase C dedifferentiate thyroid cells by down regulating nuclear cAMP dependent protein kinase A. Genes Dev. 6:1621, 1992
30. Ginsberg, J., Murrary, P.G.: The effects of TSH receptor antibodies on protein kinase C in the thyroid. Clin. Endocrinol. (Oxf.) 38:45, 1993